The efficacy of oligonucleotide chip detecting YMDD mutants of hepatitis B virus in lamivudine-treated patients.

被引:0
|
作者
Heo, J
Cho, M
Kim, GH
Kang, DH
Song, GA
Yang, US
Jang, HJ
Park, HK
Kim, CM
Kim, HH
Cho, BM
Shin, WW
机构
[1] Pusan Natl Univ, Coll Med, Pusan, South Korea
[2] Pusan Natl Univ, Coll Nat Sci, Pusan, South Korea
[3] Donga Univ, Coll Med, Pusan, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1163
引用
收藏
页码:716A / 717A
页数:2
相关论文
共 50 条
  • [41] Clinal picuture of patients with YMDD mutants who had not been treated with lamivudine.
    Kumashiro, R
    Ide, T
    Kobayasi, S
    Murashima, S
    Ogata, K
    Hisamochi, A
    Koga, Y
    Hino, T
    Ueno, T
    Sata, M
    HEPATOLOGY, 2001, 34 (04) : 315A - 315A
  • [42] Evaluation of HBxAg/anti-HBx in lamivudine treated hepatitis B patients.
    Hann, HWL
    Son, J
    Clayton, MM
    Feitelson, MA
    HEPATOLOGY, 1998, 28 (04) : 725A - 725A
  • [43] Detection and analysis of point mutation of HBV (hepatitis B virus) YMDD motif in patients with lamivudine resistant
    Pan, Xiaoping
    Li, Lanjuan
    Du, Weibo
    Sheng, Guoping
    Zhang, Yinmin
    Cao, Hongcui
    Li, Minwei
    Chen, Zhi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A94 - A94
  • [44] Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B
    Liu, Zheng-Wen
    Han, Qun-Ying
    Zhang, Ni
    Kang, Wen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (07) : 972 - 976
  • [45] Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B
    You-Wen Tan
    Yun Ye
    Guo-Hong Ge
    Wei Zhao
    Jian-He Gan
    Yun Zhao
    Zhi-Lin Niu
    Dong-Jun Zhang
    Li Chen
    Xue-Jun Yu
    Li-Jun Yang
    World Journal of Gastroenterology, 2015, (07) : 2089 - 2095
  • [46] Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B
    Tan, You-Wen
    Ye, Yun
    Ge, Guo-Hong
    Zhao, Wei
    Gan, Jian-He
    Zhao, Yun
    Niu, Zhi-Lin
    Zhang, Dong-Jun
    Chen, Li
    Yu, Xue-Jun
    Yang, Li-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (07) : 2089 - 2095
  • [47] The efficacy of lamivudine in acute viral hepatitis with hepatitis B virus
    Apostolescu, CG
    Rebedea, I
    Coltan, G
    Iacob, SA
    Caruntu, FA
    JOURNAL OF HEPATOLOGY, 2001, 34 : 144 - 144
  • [48] Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B
    Zhou, Rui
    Pan, Fan
    Lin, Chun
    Lin, Xiuquan
    Gao, Haibing
    Huang, Shuiwen
    Huang, Zuxiong
    Lin, Yong
    Pan, Chen
    Zhou, Yuanping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 19258 - 19265
  • [49] Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
    Liu, Hongcan
    Wan, Zemin
    She, Lanhui
    Zhu, Yajuan
    Cai, Zhiliang
    Wu, Bin
    Zhuang, Qizhen
    Ke, Peifeng
    Wu, Xinzhong
    Li, Zhuo
    Huang, Xianzhang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Identification of lamivudine-resistant hepatitis B virus by oligonucleotide microarray
    Kang, Jung-A
    Park, Jae-Chan
    Kim, Jong-Man
    Chai, Young-Guy
    Lee, Kyoung-Ryul
    BIOCHIP JOURNAL, 2007, 1 (04) : 273 - 280